General Anesthesia

General Anesthesia Pharmacology

MedicationMechanismPharmacokineticsPrimary Effects/UsesAdvantagesAdverse Effects/Disadvantages
BarbituratesEnhance GABAA receptor–mediated inhibitionHepatic metabolism with redistribution; prolonged sedation with repeated dosesInduction of anesthesia; reduce CMRO₂, ICP, and CBF; anticonvulsantRapid onset via redistribution; potent anticonvulsantDose-dependent CNS depression, myocardial depression, cough/laryngospasm (esp. in asthmatics), histamine release
PropofolEnhances GABAA receptor functionHepatic & extrahepatic metabolism with fast redistributionRapid induction of unconsciousness; CNS depression; decreased ventilatory driveAntiemetic; ideal for day-case surgery; no histamine releaseMarked hypotension; respiratory depression
EtomidateEnhances GABAA receptor functionEffect terminated by rapid redistributionInduction of anesthesia particularly in cardiovascularly unstable patientsShort acting; CVS and RS stability in elderly/shocked patientsNausea, vomiting; adrenal suppression (even after a single dose)
KetamineNoncompetitive NMDA receptor antagonistIV onset within 30–60 s; redistribution halts effect in 15–20 minutesInduction of general anesthesia & analgesia; preserves airway reflexesMaintains CV stability in shock; bronchodilator; preserves respiratory driveIncreases HR and BP (not ideal in hypertensives); excess salivation; emergence agitation & hallucinations; contraindicated in head trauma
BenzodiazepinesIncrease GABAA receptor affinity for GABAEffects terminated by redistributionSedation, anxiolysis, amnesia, anticonvulsant effects; used in withdrawal protocolsUseful for managing insomnia, anxiety & CNS depressant withdrawalSomnolence; cognitive deficits; tolerance; dependence; disinhibition (reversal possible with flumazenil)
OpioidsBind opioid receptors (agonism)Generally metabolized hepatically; varies by agentProvide analgesia; modest CNS depressionAgents like fentanyl provide potent analgesia with cardiac stability; various options (fentanyl, alfentanil, etc.)Respiratory depression; nausea/vomiting; sedation; miosis; hypotension (histamine release with morphine); agent-specific adverse effects
Neuromuscular Blocking DrugsBlock neuromuscular transmissionVaried (e.g., succinylcholine has rapid onset, others rely on metabolism and elimination)Facilitate tracheal intubation; optimize surgical field through muscle relaxationRapid onset with certain agents (e.g., succinylcholine, rocuronium); various options for duration and reversal (anticholinesterases, sugammadex)Depolarizing agents (e.g. succinylcholine): hyperkalemia, malignant hyperthermia, myalgia, anaphylaxis; nondepolarizing agents require reversal and may cause cholinergic side effects
All Decreases CNS, Heart, Lungs except ketamine and eto for heart only protective
MedicationMechanismPharmacokineticsPrimary Effects/UsesAdvantagesAdverse Effects/Disadvantages
Inhaled Anesthetic Agents (General)Modulate various CNS channels (GABAA, glycine, glutamate)Low blood/tissue solubility → rapid onset; eliminated mainly by exhalationProduce unconsciousness and amnesia; affect multiple organ systemsNoninvasive delivery; easy titrationCan cause dose-dependent respiratory & cardiovascular depression; some agents may trigger malignant hyperthermia; environmental concerns
Nitrous Oxide
104%
NMDA receptor antagonistMinimal metabolism; rapid elimination via the lungsWeak anesthetic producing analgesia; typically used as an adjunctMild CV and respiratory effects; rapid onset and offsetNausea/vomiting; expansion of closed gas spaces; diffusion hypoxia; inhibits vitamin B12 metabolism
Desflurane
6%
Volatile agent acting via modulation of CNS ion channelsVery low solubility yields ultrarapid induction/recovery; negligible metabolismRapid induction and emergence suited for outpatient proceduresMinimal metabolism; very fast recoveryPungent, irritating airway requiring special vaporizer; high concentrations may increase BP & HR
Sevoflurane
1.85%
Volatile agent acting via CNS ion channel modulationLow blood solubility yields rapid induction/emergence; minimal metabolismGeneral anesthesia; particularly well tolerated in childrenPleasant odor; excellent bronchodilation; minimal HR effectDegradation by CO₂ absorbents produces Compound A
Isoflurane
1.15%
Volatile agent modulating synaptic transmissionModerate, leading to slower recovery than agents with low solubilityMaintenance of anesthesia with predictable controlCauses peripheral vasodilation and augments coronary blood flowSlower recovery; may sensitize the myocardium to catecholamines
Halothane
0.75%
Volatile agent affecting multiple ion channelsHigh solubility leads to prolonged emergenceHistorically used in children for induction (sweet odor); smooth inductionPleasant odor; reduces BP effectivelySensitizes myocardium to catecholamines; risk of halothane hepatitis; prolonged recovery

all increase icp

Steps of GA

  1. Induction (hypnotic, analgesia, muscle relaxant)
  2. Maintenance
  3. Recovery (reversal)

Types of Induction of General Anesthesia

  • Intravenous
  • Inhalational

Physiological Changes During General Anesthesia

  • Depress ventilatory control, depress ventilation and muscle movement, leading to hypercapnia and hypoxemia.
  • Loss of airway reflex and gag response because of CNS depression, which may lead to aspiration of stomach contents.
  • Patient needs immediate support of his airway and start controlled ventilation.
  • Anesthesia agent leads to depress myocardial contractility and rate, leading to hypotension and organ hypoperfusion.
  • It leads to either direct or indirect SVR reduction, which also leads to hypotension and organ injury.
  • Patient will not move, this may lead to body injury if not monitored and protected by anesthesiologist during surgery.

Risks (Complications) of GA

Common Risks to General Anesthesia

  1. Sore throat due to gas or tube used for breathing may notice difficulty in speaking but improves with time.
  2. Temporary pain in the muscle.
  3. Hypothermia for preterm and newborns leading to a drop in blood circulation and respiratory.
  4. The risk of apnea in preterm infants aged less than 60 weeks, which requires the need to enter ICU.

Uncommon Risks of General Anesthesia / Sedation

  1. Awareness of the operating room activity during surgery such as caesarean section, cardiac operations.
  2. Eye contact may be accompanied by pain and may need medical treatment.
  3. Damage to teeth, lips, and tongue.
  4. Memory dysfunction.

Rare Risks of General Anesthesia That May Cause Brain Damage, Neurological Disability or Death

  1. Airway obstruction that cannot be controlled quickly and difficulty intubation, leading to severe lack of oxygen.
  2. Pulmonary aspiration causing pneumonia, hypoxia, and death. Risk is more with obesity and in pregnant women and in non-fasting patients.
  3. Severe allergic reactions to anesthetics and other medications may cause difficulty breathing, skin rashes, hypotension, and cardiac arrest.

Risks increase with elderly patients, premature infants, and children under one year of age who suffer from chronic diseases such as heart disease, chest, arteries, pressure, diabetes, liver, and kidney disease, smokers, and obesity.

(ASA) Defines of (Level of Sedation / Analgesia)

DescriptionMinimal SedationModerate Sedation / AnalgesiaDeep Sedation / AnalgesiaGeneral Anesthesia
ResponsivenessNormal response to verbal stimulationPurposeful response to verbal or tactile stimulationPurposeful response following repeated or painful stimulationUnarousable even with painful stimulus
AirwayUnaffectedNo intervention requiredIntervention may be requiredIntervention often required
Spontaneous VentilationUnaffectedAdequateMay be inadequateFrequently inadequate
CardiovascularUnaffectedUsually maintainedUsually maintainedMay be impaired